These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 2731008

  • 1. 99mTc-nanocolloid bone marrow scintigraphy in prostatic cancer.
    Haddock G, Gray HW, McKillop JH, Bessent RG, Kirk D.
    Br J Urol; 1989 May; 63(5):497-502. PubMed ID: 2731008
    [Abstract] [Full Text] [Related]

  • 2. Colloid scintigraphy showing red bone marrow extension in patients with prostatic carcinoma.
    Rudberg U, Udén R, Ahlbäck SO.
    Acta Radiol; 1992 Mar; 33(2):97-102. PubMed ID: 1562417
    [Abstract] [Full Text] [Related]

  • 3. [Bone marrow scintigraphy using radiocolloids in bone metastases. Sensitivity, specificity, reliability and indications].
    Fritz P, Adolph J, Bubeck B, Georgi P, zum Winkel K.
    Rofo; 1986 Jun; 144(6):689-95. PubMed ID: 3012705
    [Abstract] [Full Text] [Related]

  • 4. [The usefulness of bone marrow scintigraphy in the detection of bone metastasis from prostatic cancer].
    Otsuka N, Fukunaga M, Morita R, Sone T, Yoneda M, Saito N, Tanaka H, Tomomitsu T, Yanagimoto S, Muranaka A.
    Kaku Igaku; 1985 Feb; 22(2):169-76. PubMed ID: 3159922
    [No Abstract] [Full Text] [Related]

  • 5. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
    Limouris GS, Voliotopoulos V, Stavraka A, Vlahos L.
    Anticancer Res; 1997 Feb; 17(3B):1615-8. PubMed ID: 9179204
    [Abstract] [Full Text] [Related]

  • 6. Bone marrow scintigraphy in small cell carcinoma of the lung.
    Li DJ, Maughan TS, Miles KA, Wraight EP.
    Nucl Med Commun; 1994 Jan; 15(1):29-33. PubMed ID: 8152690
    [Abstract] [Full Text] [Related]

  • 7. The usefulness of bone-marrow scintigraphy in the detection of bone metastasis from prostatic cancer.
    Otsuka N, Fukunaga M, Sone T, Yoneda M, Saito N, Tanaka H, Tomomitsu T, Yanagimoto S, Muranaka A, Morita R.
    Eur J Nucl Med; 1985 Jan; 11(8):319-22. PubMed ID: 4076240
    [Abstract] [Full Text] [Related]

  • 8. Bone and bone marrow scintigraphy in the diagnosis of neoplastic involvement of the skeletal system. A comparative analysis.
    Sacchi S, Marietta M, Rinaldi G, Pantusa M, Romani F, Zaniol P, Torelli U.
    J Nucl Med Allied Sci; 1987 Jan; 31(3):255-60. PubMed ID: 3694273
    [No Abstract] [Full Text] [Related]

  • 9. Bone marrow scintigraphy in prostatic carcinomas.
    Bourgeois P, Malarme M, Van Franck R, Wauters G, Ferremans W.
    Nucl Med Commun; 1991 Jan; 12(1):35-45. PubMed ID: 2023692
    [Abstract] [Full Text] [Related]

  • 10. Clinical evaluation of the bone marrow imaging agent 99Tcm-phytate in the detection of bone metastases.
    Chang CP, Liu RS, Yu SM, Wynchank S, Chu LS, Shiau HY, Cheng TC.
    Nucl Med Commun; 1996 Dec; 17(12):1030-4. PubMed ID: 9004298
    [Abstract] [Full Text] [Related]

  • 11. [Patterns of bone metastases of carcinoma of the prostate: evaluation using 99mTC-MDP bone scintigraphy].
    Matsuda H, Sakashita S, Arakawa M, Koyanagi T.
    Nihon Hinyokika Gakkai Zasshi; 1987 Oct; 78(10):1809-13. PubMed ID: 3444173
    [No Abstract] [Full Text] [Related]

  • 12. Scintigraphy with nanocolloid Tc 99m in patients with small cell lung cancer, with special reference to bone marrow and hepatic metastasis.
    Widding A, Stilbo I, Hansen SW, Hansen HH, Rossing N.
    Eur J Nucl Med; 1990 Oct; 16(8-10):717-9. PubMed ID: 2166669
    [Abstract] [Full Text] [Related]

  • 13. [Pathogenetic differentiation of the bone superscan using bone marrow scintigraphy].
    Weckesser M, Müller-Mattheis VG, Vosberg H, Müller-Gärtner HW.
    Nuklearmedizin; 1998 Jun; 37(4):156-8. PubMed ID: 9650218
    [Abstract] [Full Text] [Related]

  • 14. Bone marrow scintigraphy in the diagnosis of post-traumatic avascular necrosis of bone.
    Tawn DJ, Watt I.
    Br J Radiol; 1989 Sep; 62(741):790-5. PubMed ID: 2790419
    [Abstract] [Full Text] [Related]

  • 15. Gastrointestinal activity following bone marrow scintigraphy with technetium-99m nanocolloid in patients with multiple myeloma.
    Agren B, Måre K, Aspelin P.
    Eur J Nucl Med; 1995 Nov; 22(11):1319-22. PubMed ID: 8575484
    [Abstract] [Full Text] [Related]

  • 16. Comparison of immunoscintigraphy and colloid scintigraphy of bone marrow.
    Munz DL, Sandrock D, Rilinger N.
    Lancet; 1990 Jul 28; 336(8709):258-9. PubMed ID: 1973815
    [No Abstract] [Full Text] [Related]

  • 17. Preserved value of bone scintigraphy for the detection of skeletal metastases in prostate cancer patients with low prostate-specific antigen levels: effect of hormonal therapy and poor histologic differentiation.
    Caglar M, Tuncel M.
    Clin Nucl Med; 2002 Jul 28; 27(7):532-3. PubMed ID: 12072787
    [No Abstract] [Full Text] [Related]

  • 18. The usefulness of 99mTc-HMPAO-labeled leukocyte scintigraphy in the diagnosis of skeletal metastases of cancers.
    Kinoshita M, Imai Y, Fujiwara K, Miyamae T.
    Ann Nucl Med; 2000 Apr 28; 14(2):103-9. PubMed ID: 10830527
    [Abstract] [Full Text] [Related]

  • 19. Bone marrow immunoscintigraphy versus conventional bone scintigraphy in the diagnosis of skeletal metastases in urogenital malignancies.
    Zoeller G, Sandrock D, Munz DL, Ringert RH.
    Eur Urol; 1994 Apr 28; 26(2):141-4. PubMed ID: 7957469
    [Abstract] [Full Text] [Related]

  • 20. [Comparison of skeletal scintigraphy and bone marrow scintigraphy in detection of osseous metastases].
    Bathmann J, Moser E.
    Radiologe; 1995 Jan 28; 35(1):8-14. PubMed ID: 7892445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.